Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05984589

A Prospective, Randomized, Controlled Study Comparing RISE Personalized Self-Management Training to Standardized Training in Gastrointestinal Cancer Patients

Led by University of Southern California · Updated on 2026-04-02

120

Participants Needed

2

Research Sites

65 weeks

Total Duration

On this page

Sponsors

U

University of Southern California

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating personalized self-management training (PSMT) compared to standardized self-management training (SSMT) in patients with gastrointestinal (GI) cancers, including colorectal cancer. This study is a Phase 2, prospective, randomized, controlled trial involving 120 GI cancer patients. The goal is to find out if personalized training can better help patients stick to healthy behavior recommendations. Participants will be randomly assigned to one of two groups: the personalized RISE-PSMT program or the standardized SSMT program. Both programs last six weeks and involve licensed occupational therapists with doctoral training. The RISE-PSMT includes two in-person visits and four videoconference sessions focused on setting and achieving specific health goals using motivational techniques and cognitive behavioral therapy. The SSMT group receives six standardized sessions covering physical activity, diet, alcohol use, weight management, and general healthy behavior strategies. During the study, participants will complete assessments over 12 weeks to measure adherence to healthy behaviors using the WCRF/AICR score, general self-efficacy, and health-related quality of life via questionnaires. Researchers will track changes in specific healthy behavior components and overall quality of life. Participants are expected to be ambulatory and able to complete the program independently, with informed consent required prior to participation.

CONDITIONS

Brief Title

Personalized Health Self-Management Training for Colorectal Cancer Survivors

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older at the time of consent
  • History of Stage I-IV colorectal cancer or other gastrointestinal cancer within the past 10 years
  • Ability to speak, write, and read English sufficiently to participate
  • Willingness and interest to work on at least one lifestyle-related risk factor such as diet, physical activity, body composition, or alcohol use
  • Scoring 3.5 or lower on the WCRF/AICR Health Behavior Adherence Scale or low-to-moderate adherence in any subcategory
  • Ambulatory and independent in activities of daily living
  • Written informed consent and ability to comply with study requirements
Not Eligible

You will not qualify if you...

  • Cognitive or mental impairments that would hinder participation in the program as determined by the study physician or Principal Investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Treatment

Duration - 6 weeks

Participants receive either personalized self-management training (RISE-PSMT) or standardized self-management training (SSMT) focusing on healthy behavior change over 6 weeks.

2 in-person visits and 4 videoconference sessions

Follow-up

Duration - 6 weeks

Participants are monitored for outcomes related to self-efficacy, quality of life, and health behavior adherence after the self-management program.

1 to 2 visits depending on assessments

Trial Site Locations

Total: 2 locations

1

Cedars-Sinai Medical Center

Los Angeles, California, United States, 90048

Active, Not Recruiting

2

University of Southern California

Los Angeles, California, United States, 90089

Actively Recruiting

Loading map...

Research Team

A

Alix G Sleight, PhD, OTD, MPH, OTR/L

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

A Phase 1/2a Study of the Safety, Tolerability, and Prelimin...

Castration-Resistant Prostate Cancer (CRPC)

Actively Recruiting

4 locations

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

A Phase 1/2a Study Utilizing 64Cu-LNTH-1363S (64Cu Radiolabe...

Metastatic Sarcoma

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here